Impaired expression of HLA-I APM components is a frequent event in solid tumors when compared to non-malignant cells, thereby progressively inhibiting the ability of CD8+ CTL to recognize tumor cells [7,38,43,44,45]. This evidence concerns the gene CD8A and neoplasm.